Skip to main content
Javad Parvizi, MD, Orthopaedic Surgery, Philadelphia, PA, Thomas Jefferson University Hospital

JavadParviziMD

Orthopaedic Surgery Philadelphia, PA

Hip & Knee Reconstructive Surgery

Professor of Orthopedic Surgery, Thomas Jefferson University

Dr. Parvizi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Parvizi's full profile

Already have an account?

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Residency, Orthopaedic Surgery, 1997 - 2002
  • Mayo Foundation, Rochester
    Mayo Foundation, RochesterMS, Orthopaedic, 1997 - 1999
  • University of Sheffield School of Medicine
    University of Sheffield School of MedicineClass of 1991

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2006 - 2025
  • PA State Medical License
    PA State Medical License 2002 - 2024
  • TX State Medical License
    TX State Medical License 2015 - 2015
  • MN State Medical License
    MN State Medical License 1999 - 2002
  • American Board of Orthopaedic Surgery Orthopaedic Surgery

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2011-2014
  • Philadelphia Magazine Castle Connolly, 2010-2014
  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • A Novel Mutation in Teneurin 3 Found to Co‐Segregate in All Affecteds in a Multi‐Generation Family with Developmental Dysplasia of the Hip*  
    Javad Parvizi, MD, Journal of orthopaedic research
  • Vancomycin Prophylaxis for Total Joint Arthroplasty: Incorrectly Dosed and Has a Higher Rate of Periprosthetic Infection Than Cefazolin  
    Michael M. Kheir MD, Timothy L. Tan MD, Ibrahim Azboy MD, Dean D. Tan BS, Javad Parvizi MD, FRCS, Clinical Orthopaedics and Related Research, 4/11/2017
  • Prevention of Periprosthetic Joint Infection: Examining the Recent Guidelines  
    Noam Shohat, MD, Javad Parvizi, MD, FRCS, The Journal of Arthroplasty, 3/5/2017
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Chemokine Receptor Mutated In All Affected Members of a Large Multigeneration Family with DDH Affects Acetabular Morphology In the CX3CR1 Knockout Mouse
    Sawan H, Freeman T, Parvizi J, Feldman G., ORS, Las Vegas, NV, 1/28/2015
  • Red Cell Distribution Width: An Unacknowledged Predictor of Mortality Following Revision Arthroplasty
    Alijanipour P, Heller S, Kucukdurmaz F, Zmistowski B, Rezapoor M, Parvizi J, AAOS, Las Vegas, NV, 1/24/2015
  • Aspirin is Adequate in Prevention of Thromboembolic Events after Revision Arthroplasty
    Deirmengian GK, Smith EB, Heller S, Parvizi J., AAOS, Las Vegas, NV, 1/24/2015
  • Join now to see all

Lectures

  • Hot Topics and Contraversies in Primary THA Symposium 
    Las Vegas - 1/28/2015
  • How Do I Get out of This Jam 
    Las Vegas - 1/28/2015
  • Infection Controversies Mini-Debates 
    Las Vegas - 1/28/2015
  • Join now to see all

Other

Press Mentions

  • Peptilogics Reports Positive 90-Day Top Line Interim Data from Phase 1b Trial of PLG0206 in Patients with Periprosthetic Joint Infection (PJI)
    Peptilogics Reports Positive 90-Day Top Line Interim Data from Phase 1b Trial of PLG0206 in Patients with Periprosthetic Joint Infection (PJI)May 24th, 2023
  • Genetic Study Explores the Microbiome of Hip and Knee Osteoarthritis
    Genetic Study Explores the Microbiome of Hip and Knee OsteoarthritisMay 18th, 2023
  • Javad Parvizi, M.D. Now President of AAHKS
    Javad Parvizi, M.D. Now President of AAHKSApril 5th, 2023
  • Join now to see all

Hospital Affiliations